Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1938]
News [3134]
Articles [127]
Editorials [3]
Conferences [119]
elearning [13]
Study shows pomalidomide prolongs survival in refractory myeloma patients
Prof Jesus San Miguel - University Hospital of Salamanca, Salamanca, Spain
Study shows pomalidomide prolongs survival in refractory myeloma patients ( Prof Jesus San Miguel - University Hospital of Salamanca, Salamanca, Spain )
18 Jun 2013
Use of Daratumumab, a CD38 monoclonal antibody, in advanced multiple myeloma
Prof Heinrich Lokhorst - Universitair Medisch Centrum Utrecht, Heidelberglaan...
Use of Daratumumab, a CD38 monoclonal antibody, in advanced multiple myeloma ( Prof Heinrich Lokhorst - Universitair Medisch Centrum Utrecht, Heidelberglaan, Netherlands )
18 Jun 2013
Targeting JAK-STAT pathway in malignant and non-malignant cells in...
Dr Ross Levine - Memorial Sloan-Kettering Cancer Center, New York, USA
Targeting JAK-STAT pathway in malignant and non-malignant cells in myeloproliferative neoplasms ( Dr Ross Levine - Memorial Sloan-Kettering Cancer Center, New York, USA )
18 Jun 2013
Addition of obinutuzumab or rituximab to chlorambucil for chronic lymphocytic...
Dr Valentin Goede - University Hospital of Cologne, Germany
Addition of obinutuzumab or rituximab to chlorambucil for chronic lymphocytic leukaemia ( Dr Valentin Goede - University Hospital of Cologne, Germany )
18 Jun 2013
Daratumumab, a CD38 monoclonal antibody study in advanced multiple myeloma
Prof Heinrich Lokhorst - Universitair Medisch Centrum Utrecht, Heidelberglaan...
Daratumumab, a CD38 monoclonal antibody study in advanced multiple myeloma ( Prof Heinrich Lokhorst - Universitair Medisch Centrum Utrecht, Heidelberglaan, Netherlands )
17 Jun 2013
Monoclonal antibodies and targeting them against cancer cells in lymphoma
Prof Ronald Levy - Stanford University, USA
Monoclonal antibodies and targeting them against cancer cells in lymphoma ( Prof Ronald Levy - Stanford University, USA )
14 Jun 2013
Neo-angiogenesis and pathological angiogenesis in targeted molecules
Dr Wolfgang Wick - University of Heidelberg, Germany
Neo-angiogenesis and pathological angiogenesis in targeted molecules ( Dr Wolfgang Wick - University of Heidelberg, Germany )
14 Jun 2013
Role of microenvironment and stroma in cancer therapy
Dr Stephen Ansell - Mayo Clinic, Rochester, USA
Role of microenvironment and stroma in cancer therapy ( Dr Stephen Ansell - Mayo Clinic, Rochester, USA )
7 Jun 2013
Brentuximab vedotin in the frontline setting
Dr Stephen Ansell - Mayo Clinic, Rochester, USA
Brentuximab vedotin in the frontline setting ( Dr Stephen Ansell - Mayo Clinic, Rochester, USA )
2 Jun 2013
Durable survival benefit for thalidomide consolidation in multiple myeloma post...
Dr Anna Kalff - Alfred Hospital, Melbourne, Australia
Durable survival benefit for thalidomide consolidation in multiple myeloma post ASCT ( Dr Anna Kalff - Alfred Hospital, Melbourne, Australia )
6 Apr 2013
Report from the Asian Myeloma Network
Dr J.H. Lee - Gachon University Gil Medical Center, Incheon, Republic of Korea
Report from the Asian Myeloma Network ( Dr J.H. Lee - Gachon University Gil Medical Center, Incheon, Republic of Korea )
6 Apr 2013
Japan Myeloma Network
Dr Hiroshi Kosugi - Ogaki Municipal Hospital, Ogaki, Japan
Japan Myeloma Network ( Dr Hiroshi Kosugi - Ogaki Municipal Hospital, Ogaki, Japan )
6 Apr 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation